Streptococcus Pneumoniae Infection

2

Review clinical trials related to Streptococcus Pneumoniae Infection. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

Clinical Trial of the 24-valent Pneumococcal Polysaccharide Conjugate Vaccine (CRM197/Tetanus Toxoid)

This clinical trial consists of Phase I and Phase II. The objective is to evaluate the safety and immunogenicity of the 24-valent pneumococcal polysaccharide conjugate vaccine (CRM197/tetanus toxoid) in individuals aged 2 months (minimum 6 weeks) and older.

Participants needed: 854
Trial details
Phase: Phase 1, Phase 2Age: 6+Biological sex: AllType: InterventionalSponsor: CanSino Biologics Inc.Updated: May 22, 2026
Eligibility criteria

Individuals aged 2 months (minimum 6 weeks), 7 months to 5 years, and 18 years a... [+9]

Preterm birth (delivery before 37 weeks of gestation), low birth weight (<2500 g... [+18]

Status: Not yet recruiting

Epidemiology and Household Transmission of Streptococcus Pneumoniae and Respiratory Syncytial Virus

This household-based prospective cohort study aims to stablish the household transmission of Respiratory syncytial virus and S. pneumoniae especially in the elderly and infants/children as well as inter-relationship between S. pneumoniae and Respiratory syncytial virus.

Participants needed: 240
Trial details
Biological sex: AllType: ObservationalSponsor: Mackay Memorial HospitalUpdated: Aug 24, 2021Duration: 2 Years
Eligibility criteria

Indicator case: Babies under 5 months of age were born in Mackay Children's Hosp... [+2]

Babies older than 5 months [+5]